论文部分内容阅读
目的通过对住院儿童社区获得性肺炎(CAP)单病种管理临床路径实施情况分析,评价临床路径对出院患儿费用的影响。方法选择2013年7月1日-2013年12月31日出院患儿符合CAP的患者247例作为非路径组,同期收治符合CAP的患者241例作为路径组,将两组进行比较分析。结果路径组患儿的住院时间较非路径组缩短0.856天(P<0.05),差异有统计学意义;住院费用较非路径组减少669元(P<0.05),差异有统计学意义。路径组患儿住院费用的减少主要包括床位费、护理费、化验费、诊疗费和药品费的减少。结论临床路径管理在儿童CAP单病种管理的应用,可缩短患儿住院天数,住院总费用及各项具体费用均得到明显的控制,使得患儿住院诊疗措施合理化,减少诊疗过程中的随意性和过度医疗的发生。
Objective To evaluate the impact of clinical pathways on the costs of discharged children by analyzing the implementation of clinical pathways of hospitalized children with community-acquired pneumonia (CAP) single disease. Methods From July 1, 2013 to December 31, 2013, 247 CAP patients were selected as non-route group and 241 patients were enrolled as CAP group. The two groups were compared and analyzed. Results The length of hospital stay of pathology group was 0.856 days shorter than that of non-path group (P <0.05), and the difference was statistically significant. The cost of hospitalization was 669 yuan less than that of non-path group (P <0.05), and the difference was statistically significant. The reduction of hospitalization costs for children in the path group mainly includes the reduction of bed fees, nursing fees, laboratory fees, medical expenses and drug fees. Conclusion The application of clinical path management in the management of children with single-disease CAP can shorten the hospitalization days, the total cost of hospitalization and the specific costs were significantly controlled, making the hospitalization of patients with reasonable treatment measures to reduce randomness in the treatment process And over-medical emergencies.